New Delhi: Serum Institute to enroll kids aged between 7 to 11 years old for Covid-19 vaccine trial as India's drug regulator has given their nod on Tuesday.
According to reports more than 870 million doses have already been administered among adult people.
Serum Institute is already conducting a trial of its COVID-19 vaccine Covovax, a domestically produced version of Novavax's shot, in the 12-17 age group and has presented safety data for an initial 100 participants.
However, the Indian health authorities yet to granted approval to the Novavax vaccine.
Earlier, The Centre on Tuesday extended the Covid-19 containment measures across the country till October 31, 2021 in view of some localized spreads of pandemic in a few states. In a communication with the Chief Secretaries and Administrators of the Union Territories (UTs), the Union Home Secretary Ajay Kumar Bhalla said that considering the need to prevent any potential rise in number of cases in view of the upcoming festive season in the country, on the direction of the National Disaster Management Authority (NDMA), the undersigned to issue an Order, for containment of COVID-19 in the country and in exercise of the powers, conferred under Section 10(2)(i) of the DM Act, the undersigned, hereby directs the State/UT Governments and State/UT Authorities to consider implementation of Prompt & Effective Containment Measures, as conveyed vide aforesaid MoHFW advisory dated 21 September, 2021, until 31.10.2021. The States/UTs, will take the necessary measures, under the relevant provisions of the DM Act", the Home Ministry communication reads.
Also Read: Assam Issued New SOP To Restart Physical Classes Of Schools, Degree Colleges And Universities